All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

ViewsDownloads

Relative Articles

More...
-  2018 

Tolerability and clinical efficacy of inhaled treprostinil in patients with group 1 pulmonary arterial hypertension

DOI: 10.1177/2040622318779749

Keywords: treprostinil, pulmonary arterial hypertension

Full-Text   Cite this paper   Add to My Lib

Abstract:

Treprostinil is a prostacyclin analogue that directly vasodilates pulmonary and systemic arterial vascular beds. The United States Food and Drug Administration approved inhaled treprostinil in July 2009 for the treatment of group 1 pulmonary arterial hypertension. Inhaled treprostinil avoids issues with continuous infusion prostanoids. This study describes a single institutional experience with inhaled treprostinil

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133